При пациенти с бъбречна дисфункция не е необходима промяна в дозировката на абакавир.
Whilst no dosage adjustment of abacavir is necessary in patients with renal dysfunction, lamivudine and zidovudine concentrations are increased in patients with renal impairment due to decreased clearance.